BUY Pricol Limited — Goldman Sachs
byGoldman SachsHorizon: NA (inferred 1 year)6 Nov 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·6 Nov · yesterday
Pricol reported Q2 FY27 consolidated revenue of INR 1,334.02 Cr (up 35.03% YoY) and PAT of INR 85.21 Cr (up 33.16% YoY). H1 FY27 PAT grew 33.68% YoY to INR 152.23 Cr.
BSE · Company Update·4 Nov · 3d ago
Pricol Limited reported Q2 FY27 consolidated revenue of INR 1,334.02 crore, up 35.03% YoY, and a PAT of INR 85.21 crore, reflecting a 33.16% YoY growth.
NSE · Press Release·4 Nov · 3d ago
Pricol Limited reported standalone revenue of Rs 1,018.23 crore and net profit of Rs 63.98 crore for the quarter ended September 30, 2026, showing growth compared to the previous year.
NSE · Outcome of Board Meeting·4 Nov · 3d ago
Pricol Limited reported standalone and consolidated financial results for the quarter and half year ended September 30, 2026, showing growth in revenue and profit compared to the previous year.
BSE · Board Meeting·4 Nov · 3d ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Pricol
- BUY — Ansh Jogendra Bhilwar5 Nov 2026 · Same day · target ₹707 · Expired
- BUY — Pradeep Haldar, PHD Capital16 Oct 2026 · ~2 weeks · target ₹765 · SL hit
- BUY — Axis Securities7 Sept 2026 · ~1 year · target ₹935 · Active
- BUY — Manas Jaiswal12 Aug 2026 · ~2 weeks · target ₹840 · SL hit
- BUY — Kunal Saraogi12 Aug 2026 · ~3 months · target ₹1,050 · Active
More from Goldman Sachs
- BUY Mahindra & Mahindra6 Nov 2026 · ~1 year · target ₹3,850 · Active
- BUY Titan Company6 Nov 2026 · ~1 year · target ₹5,800 · Active
- BUY UNO Minda6 Nov 2026 · ~1 year · target ₹1,600 · Active
- BUY Aurobindo Pharma6 Nov 2026 · ~1 year · target ₹2,000 · Active
- BUY Apollo Hospitals Enterprise6 Nov 2026 · ~1 year · target ₹10,150 · Active

